β-amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors

GLIA

Volumn 61, Issue 10, 2013, Pages 1673-1686

  Shrivastava, Amulya Nidhi ^a   Kowalewski, Jacob M ^a,b   Renner, Marianne ^a   Bousset, Luc ^c   Koulakoff, Annette ^b   Melki, Ronald ^c   Giaume, Christian ^b   Triller, Antoine ^a  

^a INSERM   (France)

^b Centre de Recherche Interdisciplinaire en Biologie   (France)

^c Laboratoire d'Enzymologie et Biochimie Structurales   (France)

Author keywords

amyloid (A ) oligomers; Alzheimer's disease; ATP; MGluR5s; Neuroglia signaling; Single particle tracking

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; METABOTROPIC RECEPTOR 5; OLIGOMER; PURINERGIC RECEPTOR; QUANTUM DOT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CONTROLLED STUDY; DIFFUSION COEFFICIENT; IMMUNOCYTOCHEMISTRY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALZHEIMER'S DISEASE; ATP; MGLUR5S; NEUROGLIA SIGNALING; SINGLE PARTICLE TRACKING; Β-AMYLOID (AΒ) OLIGOMERS;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; APYRASE; ASTROCYTES; CALCIUM; CELL COMMUNICATION; CELLS, CULTURED; CEREBRAL CORTEX; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NEURONS; PRESENILIN-1; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, METABOTROPIC GLUTAMATE 5; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84882922307     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22548     Document Type: Article

References (48)

1. Abramov AY, Canevari L, Duchen MR. 2003. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23:5088-5095.
2. Abeti R, Abramov AY, Duchen, MR. 2011. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 134:1658-1672.
3. Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL. 1999. Occurrence of the diffuse amyloid beta-protein (A beta) deposits with numerous A beta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia 25:324-331.
4. Aronica E, Catania MV, Geurts J, Yankaya B, Troost D. 2001. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: Upregulation in reactive astrocytes. Neuroscience 105:509-520.
5. Bannai H, Lévi S, Schweizer C, Dahan M, Triller A. 2006. Imaging the lateral diffusion of membrane molecules with quantum dots. Nat Protoc 1:2628-2634.
6. Casley CS, Lakics V, Lee HG, Broad LM, Day TA, Cluett T, Smith MA, O'Neill MJ, Kingston AE. 2009. Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-beta peptide. Brain Res 1260:65-75.
7. Dahan M, Lévi S, Luccardini C, Rostaing P, Riveau B, Triller A. 2003. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302:442-445.
8. D'Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, Catania MV. 2008. Metabotropic glutamate receptors in glial cells. Neurochem Res 33:2436-2443.
9. Decker H, Jürgensen S, Adrover MF, Brito-Moreira J, Bomfim TR, Klein WL, Epstein AL, De Felice FG, Jerusalinsky D, Ferreira ST. 2010. N-Methyl-d-aspartate receptors are required for synaptic targeting of Alzheimer's's toxic Aβ oligomers. J Neurochem 115:1520-1529.
10. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD. 2001. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 21:4125-4133.
11. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP. 2006. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Neurobiol Dis 24:516-524.
12. Geurts JJ, Wolswijk G, Bö L, van der Valk P, Polman CH, Troost D, Aronica E. 2003. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 126:1755-1766.
13. Halassa MM, Haydon PG. 2010. Integrated brain circuits: Astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72:335-355.
14. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356.
15. Heinrich A, Andó RD, Túri G, Rózsa B, Sperlágh B. 2012. K+ depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: A microelectrode biosensor study. Br J Pharmacol 167:1003-1020.
16. Heneka MT, Rodríguez JJ, Verkhratsky A. 2010. Neuroglia in neurodegeneration. Brain Res Rev 63:189-211.
17. Hennekinne L, Colasse S, Triller A, and Renner M. 2013. Differential control of thrombospondin over synaptic glycine and AMPA receptors in spinal cord neurons. J Neurosci 33:11432-11439.
18. Huang Y, Mucke L. 2012. Alzheimer's mechanisms and therapeutic strategies. Cell 148:1204-1222.
19. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, Younkin SG, Borchelt DR. 2004. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13:159-170.
20. Jung ES, An K, Hong HS, Kim JH, Mook-Jung I. 2012. Astrocyte-originated ATP protects Aβ(1-42)-induced impairment of synaptic plasticity. J Neurosci 32:3081-3087.
21. Kabogo D, Rauw G, Amritraj A, Baker G, Kar S. 2010. β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices. Neurobiol Aging 31:1164-1172.
22. Koffie RM, Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, Hyman BT, Spires-Jones, TL. 2009. Oligomeric amyloid b associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 106:4012-4017.
23. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. 2009. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer's mice. Science 323:1211-1215.
24. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL. 2007. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
25. Larson ME, Lesné SE. 2012. Soluble Aβ oligomer production and toxicity. J Neurochem 120:125-139.
26. Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. 2009. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457:1128-1132.
27. Lim D, Iyer A, Ronco V, Grolla AA, Canonico PL, Aronica E, Genazzani AA. 2013. Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB. Glia 61:1134-1145.
28. Mei X, Ezan P, Giaume C, Koulakoff A. 2010. Astroglial connexin immunoreactivity is specifically altered at Aβplaques in Aβ precursor protein/presenilin1 mice. Neuroscience 171:92-105.
29. Nielsen HM, Mulder SD, Belien JA, Musters RJ, Eikelenboom P, Veerhuis R. 2010. Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins. Glia 58:1235-1246
30. Nishitsuji K, Hosono T, Uchimura K, Michikawa M. 2011. Lipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes. J Biol Chem 286:6393-6401.
31. Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MVL, Naus CC, Giaume C, Sáez JC. 2011a. ATP and glutamate released via astroglial connexin43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 118:826:840.
32. Orellana JA, Shoji KF, Abudara V, Ezan P, Amigou E, Sáez PJ, Jiang JX, Naus CC, Sáez JC, Giaume C. 2011b. Amyloid-induced death in neurons involves glial and neuronal hemichannels. J Neurosci 31:4962-4977.
33. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RF Jr, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A. 2012. Glial cells in (patho)physiology. J Neurochem 121:4-27.
34. Perea G, Navarrete M, Araque A. 2009. Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci 3:421-431
35. Price DL, Rockenstein E, Ubhi K, Phung V, MacLean-Lewis N, Askay D, Cartier A, Spencer B, Patrick C, Desplats P, Ellisman MH, Masliah E. 2010. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy-Implications for Excitotoxicity. PloS One 5:e14020.
36. Racine V, Sachse M, Salamero J, Fraisier V, Trubuil A, Sibarita JB. 2007. Visualization and quantification of vesicle trafficking on a three-dimensional cytoskeleton network in living cells. J Microsc 225:214-228.
37. Renner M, Lacor PN, Velasco PT, Xu J, Contractor A, Klein WL, Triller A. 2010. Deleterious effects of amyloid β oligomers acting as an extracellular scaffold for mGluR5. Neuron 66:739-754.
38. Ruan L, Kang Z, Pei G, Le, Y. 2009. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's's disease. Curr Alzheimer's Res 6:531-540.
39. Ryu JK, and McLarnon, JG. 2008. Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease. Neuroreport 19:1715-1719.
40. Saxton MJ, Jacobson K. 1997. Single-particle tracking: Application to membrane dynamics. Annu Rev Biophys Biomol Struct 26:373-399.
41. Scemes E, Giaume C. 2006. Astrocyte calcium waves: What they are and what they do. Glia 54:716-725.
42. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P. 2005. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051-1058.
43. Triller A, Choquet D. 2008. New concepts in synaptic biology derived from single-molecule imaging. Neuron 59:359-374.
44. Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ. 2010. Astrocytes in Alzheimer's disease. Neurotherapeutics 7:399-412.
45. Vincent AJ, Gasperini R, Foa L, Small DH. 2010. Astrocytes in Alzheimer's's disease: Emerging roles in calcium dysregulation and synaptic plasticity. J Alzheimer's Dis 22:699-714.
46. Walsh DM, Thulin E, Minogue AM, Gustavsson N, Pang E, Teplow DB, Linse S. 2009. A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J 276:1266-1281.
47. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. 2003. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453-457.
48. Zeng JW, Liu XH, He WJ, Du L, Zhang JH, Wu XG, Ruan HZ. 2008. Inhibition of ATP-induced glutamate release by MRS2179 in cultured dorsal spinal cord astrocytes. Pharmacology 82:257-263